Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with improved liver histologic outcomes.

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Mass Gen's Dr. Ali Raja explains why some were sent to the emergency room after using semaglutide injections. Raja says some of the symptoms people experienced won't require an ER visit. Raja says not ...

She breastfed her little one for just over a year, and with all the new changes in her life, she was too busy to gain weight.Also read: Study links weight loss drug to rare eye conditionIn Europe, she ...

PRESS RELEASE FROM THE MINISTRY OF HEALTH AND HUMAN SERVICES Cockburn Town, Turks and Caicos Islands, 2nd May 2025: In ...

Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

The risk for ocular problems linked to different formulations of semaglutide appear to vary, according to a new study, which ...

The New England Journal of Medicine (NEJM) published results from part 1 of the ongoing phase 3 ESSENCE trial which investigated the effects of once-weekly subcutaneous semaglutide 2.4 mg on liver ...

Semaglutide improved maximum walking distance in patients with type 2 diabetes and symptomatic peripheral artery disease.

Just today, this drug became more widely available. Some product is now facing a recall following an apparent storage error.